Future studies are required to understand if the Eomes-dependent regulation is required for TIL Treg cells to kill tumor cells or suppress anti-tumor effector cells, and how Blimp1 regulates the TIL Treg heterogeneity. The gene discussed is PRDM1; the disease is neoplasm.